Mainz, Germany

Bernd Kirschbaum


Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Bernd Kirschbaum

Introduction

Bernd Kirschbaum, an accomplished inventor based in Mainz, Germany, has made significant contributions to the field of molecular biology and biochemistry. With a robust portfolio of seven patents, his work focuses on the characterization of DEAH-box proteins and the development of pharmaceutical compounds.

Latest Patents

Kirschbaum's latest patents showcase his innovative spirit and technical expertise. One notable patent involves the identification and molecular-biological characterization of novel DEAH-box proteins, which exhibit structural similarities to other known helicases. This invention not only details the DNA sequences encoding these proteins but also demonstrates their ability to bind ATP and nucleic acids while possessing helicase and ATPase activities. Furthermore, the patent outlines processes for the preparation of such proteins and their potential uses in pharmacologically relevant test systems and therapeutic applications.

In addition, Kirschbaum has developed patents related to isoxazole and crotonamide derivatives, emphasizing their utility as pharmaceuticals and diagnostics. These advancements reflect his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Throughout his career, Bernd Kirschbaum has held pivotal roles in prominent pharmaceutical companies, including Aventis Pharma Deutschland GmbH and Hoechst Aktiengesellschaft. His experiences in these organizations have allowed him to refine his research skills and contribute to groundbreaking developments in the pharmaceutical field.

Collaborations

In his innovative journey, Kirschbaum has collaborated with esteemed colleagues such as Wilfried Schwab and Stefan Muellner. Together, they have worked on various projects that enhance the understanding and application of biopharmaceuticals, pushing the boundaries of research and development.

Conclusion

Bernd Kirschbaum's impressive portfolio and dedication to innovation have positioned him as a significant figure in the realm of molecular biology and pharmaceuticals. His inventions not only contribute to scientific knowledge but also hold the potential for transformative impacts in therapeutic applications. As he continues to explore new frontiers, Bernd Kirschbaum exemplifies the spirit of innovation that drives progress in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…